Cargando…
The TRAIL in the Treatment of Human Cancer: An Update on Clinical Trials
TRAIL (tumor-necrosis factor related apoptosis-inducing ligand, CD253) and its death receptors TRAIL-R1 and TRAIL-R2 selectively trigger the apoptotic cell death in tumor cells. For that reason, TRAIL has been extensively studied as a target of cancer therapy. In spite of the promising preclinical o...
Autores principales: | Snajdauf, Martin, Havlova, Klara, Vachtenheim, Jiri, Ozaniak, Andrej, Lischke, Robert, Bartunkova, Jirina, Smrz, Daniel, Strizova, Zuzana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006409/ https://www.ncbi.nlm.nih.gov/pubmed/33791337 http://dx.doi.org/10.3389/fmolb.2021.628332 |
Ejemplares similares
-
Tumoral and paratumoral NK cells and CD8(+) T cells of esophageal carcinoma patients express high levels of CD47
por: Strizova, Zuzana, et al.
Publicado: (2020) -
Novel Insights into the Immunotherapy of Soft Tissue Sarcomas: Do We Need a Change of Perspective?
por: Ozaniak, Andrej, et al.
Publicado: (2021) -
Rare Pseudosarcomatous Lesions Posing Diagnostic Challenges: Histopathologic Examination as a Dominant Tool Preventing Misdiagnosis of Proliferative Fasciitis
por: Ozaniak, Andrej, et al.
Publicado: (2022) -
Diagnostic challenges and treatment options in patients with solitary fibrous tumor: A single-center observational study
por: Ozaniak, Andrej, et al.
Publicado: (2022) -
Giant lung metastasis of NRAS-mutant melanoma in a 24-year-old patient with a history of BRAF-mutant conventional melanoma harboring Spitzoid morphology: a case report
por: Vachtenheim, Jiri, et al.
Publicado: (2020)